hVIVO plc (LON:HVO – Get Free Report)’s share price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 24.90 ($0.31) and traded as low as GBX 19 ($0.24). hVIVO shares last traded at GBX 19.50 ($0.24), with a volume of 606,288 shares.
hVIVO Stock Performance
The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The company’s fifty day simple moving average is GBX 24.60 and its 200 day simple moving average is GBX 27.08. The stock has a market capitalization of £133.05 million, a price-to-earnings ratio of 651.83 and a beta of 0.97.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
See Also
- Five stocks we like better than hVIVO
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 2 Drone Stocks Surging from Increased Media Attention
- Stock Splits, Do They Really Impact Investors?
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
